Biotech+ Hub at Pegasus Park

A view of Dallas’ rapidly growing Biotech hub Pegasus Park & BioLabs with UT Southwestern Medical Center in the back! Looking forward to being part of this ecosystem even after my PhD!

We’re thrilled to announce that the Cystic Fibrosis Foundation has agreed to invest up to $15 million in additional funding to accelerate our gene correction research program, developed in collaboration with Intellia Therapeutics, Inc. This support advances our work, combining our innovative SORT LNP delivery platform with Intellia’s cutting-edge CRISPR DNA-writing technology. This funding will help develop up to three unique gene correction programs, bringing hope for transformative new therapies. Together, we’re tackling the root genetic cause of cystic fibrosis (CF), initially focusing on mutations current treatments cannot adequately address. We’re proud to continue our partnership with the CF Foundation, building on their support of our inhaled mRNA therapy, RCT2100, which is now in a Phase 1b trial. Together, we are working to create new therapeutic solutions for everyone affected by this genetic disease and ensure no one is left behind. Read the full release here: https://bit.ly/48V3PPi #CysticFibrosis #Biotech #ReCode #GeneticMedicine #CRISPR

“Tens of billions of [life science] dollars” have left DFW due to a lack of lab space, said Gabby Everett, director of business operations and strategy and site head for BioLabs Pegasus Park - North Texas. Numerous investors, including DCC member organizations Lyda Hill Philanthropies and Dallas Regional Chamber, are reversing this trend by transforming Pegasus Park’s 26-acre campus into a #biotech, life sciences and #nonprofit epicenter. The life science estate recently attracted the $2.5B?federal agency ARPA-H to build its third hub on its campus. https://lnkd.in/g8JiPrhq??

???? Remote workers in the life sciences industry are thriving in Dallas-Fort Worth, where they’re part of a rapidly growing ecosystem of innovation and impact! With a robust network of #lifescience professionals, world-class research facilities, and an unbeatable quality of life, #DFW is the perfect base for remote work in this vital sector. Discover how DFW is empowering remote work and shaping the future of life sciences: https://lnkd.in/g97wG_Pm #sayyestodallas #remotework

???? ???????????????????????? ???????????????????? ????????: UT Southwestern professor Philipp Scherer talks about his work focusing on adipose cells and a local biotech company, PriveBio, that has come out of it. Dr. Scherer describes the work he is doing in areas like diabetes and fibro-inflammation. Plus, PriveBio's programs focusing on endotrophin and leptin. Full video: https://lnkd.in/gPFyGDJD BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent | Klein Hersh

???? ???????????????????????? ???????????????????? ????????: Southlake, TX based OncoNano Medicine, Inc. is harnessing nanotechnology to identify and target cancer - a lead program hits the STING pathway. CFO Matthew Head describes the company's ON-BOARD platform and how they are not only developing therapeutics, but also an imaging product that has breakthrough designation. Full Video: https://lnkd.in/gM4-8Tjy BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent | Klein Hersh

???? ???????????????????????? ???????????????????? ????????: The CEO of LH Capital / Lyda Hill Philanthropies, a key supporter of the life sciences industry in North Texas, describes the progress the biotech community here has made over the last year. Nicole Small discusses events that have recently taken place like the acquisition of Reata, ARPA-H choosing Dallas for a regional center, the buildout of Bridge Labs at Pegasus Park, and more. Full video: https://lnkd.in/gX_hzTwc BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent | Klein Hersh

???? ???????????????????????? ???????????????????? ????????: Biotech entrepreneur RA Session II describes converting science from UT Southwestern into companies - he currently has a new one that is in stealth mode. Having been involved with Reata, Taysha Gene Therapies (founder), ReCode Therapeutics and more, RA has a good handle on the biotech scene in Dallas. Full video: https://lnkd.in/gtDqEdrv BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent | Klein Hersh

???? ???????????????????????? ???????????????????? ????????: The CEO of the nonprofit MassChallenge describes the way it supports startups and entrepreneurs, and why it has chosen Dallas as its second region of major focus in the U.S. outside of Boston. Caitlin Reimers Brumme highlights MassChallenge's equity-free model and how it helps biotech entrepreneurs from the earliest stages to understanding the commercial market. Plus, the positives of Dallas for biotech and what more it can build on. Full video: https://lnkd.in/gyj9atrT BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent | Klein Hersh

???? ???????????????????????? ???????????????????? ????????: A UT Southwestern Medical Center neurology expert and the CEO of GenrAb discuss neuro-immunology and finding antibodies that can help with neuronal damage. UTSW's Benjamin Greenberg discusses how neuro-immunology is making inroads for conditions like MS, ALS, and alzheimer's. GenrAb CEO Larry Tiffany provides an update on the company's lead antibody program. Full video: https://lnkd.in/ggcCwig7 BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent | Klein Hersh